The US FDA's surveillance and pre-approval inspections of sterile drug manufacturing facilities are likely to be more consistent, streamlined and effective now that the agency is rolling out a protocol it has piloted for them.
The aseptic processing inspection protocol announced Nov. 9 is the first of several the agency plans to establish over the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?